asa guidelines for glp 1 drugs New Year, New Bod? Words of advice Plastic Surgery patients on Ozempic GLP-1 Agents vs Aspirin: A
Description
(2020, March)
Maybe these meds have been a nightmare and youre feeling more confused than ever
The CVOT of oral semaglutide in people with type 2 diabetes and established CVD, chronic kidney disease (CKD) or both demonstrated a significant reduction in MACE compared with placebo (McGuire et al, 2025)
Interesing post Maam, This represents a fundamental shift in GLP-1 therapeutics---transitioning from complex biologics to scalable small molecules like Orforglipron with clear implications for cost, access, and global supply Interesting Great & Useful Initiative mem
Metabolism and genetics Individual variations in GLP-1 receptor density and sensitivity affect how strongly any given dose activates the appetite suppression and glucose regulation pathways
Cell Stem Cell
